Assessing the delivery efficacy and internalization route of cell-penetrating peptides

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nature Protocols

• Publication date

  2007-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/nprot.2007.302PMID 17703217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Novel Cell-penetrating Peptide, M918, for Efficient Delivery of Proteins and Peptide Nucleic Acids.

  2007cited by this paper
• A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids.

  2007cited by this paper
• Handbook of cell-penetrating peptides

  2006cited by this paper
• Enhanced delivery of cell-penetrating peptide–peptide nucleic acid conjugates by endosomal disruption

  2006cited by this paper
• Induction of splice correction by cell‐penetrating peptide nucleic acids

  2006cited by this paper
• Studying the uptake of cell-penetrating peptides

  2006cited by this paper
• Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.

  2006cited by this paper
• Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).

  2006cited by this paper
• Cell-penetrating peptides: mechanisms and applications.

  2005cited by this paper
• Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.

  2005cited by this paper
• Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions*

  2005cited by this paper
• Conjugates of Antisense Oligonucleotides with the Tat and Antennapedia Cell-Penetrating Peptides: Effects on Cellular Uptake, Binding to Target Sequences, and Biologic Actions

  2004cited by this paper
• Uptake of cell-penetrating peptides is dependent on peptide-to-cell ratio rather than on peptide concentration.

  2004cited by this paper
• Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.

  2004cited by this paper
• Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis

  2004cited by this paper
• Cell-penetrating Peptides

  2003cited by this paper
• Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells.

  2003cited by this paper
• Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.

  2003cited by this paper
• Pre-mRNA splicing and human disease.

  2003cited by this paper
• [Mechanisms and applications of oral tolerance].

  1999cited by this paper
• Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development.

  1998cited by this paper

• S100A1ct: A Synthetic Peptide Derived From S100A1 Protein Improves Cardiac Performance and Survival in Preclinical Heart Failure Models

  2024cites this paper
• Unraveling mRNA delivery bottlenecks of ineffective delivery vectors by co-transfection with effective carriers.

  2024cites this paper
• Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Penetrating Peptides for Cytosolic mRNA Delivery

  2023cites this paper
• Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides

  2022cites this paper
• Delivery of antisense oligonucleotides for splice‐correction of androgen receptor pre‐mRNA in castration‐resistant prostate cancer models using cell‐penetrating peptides

  2022cites this paper
• Imaging of CPP Delivery Mechanisms of Oligonucleotides.

  2021cites this paper
• Cell-Translocation Mechanisms of CPPs

  2019cites this paper
• Improved Intracellular Delivery of Polyarginine Peptides with Cargoes.

  2019cites this paper
• Disulfide bridge as a linker in nucleic acids' bioconjugation. Part II: A summary of practical applications.

  2019cites this paper
• Methods for CPP Functionalization

  2019cites this paper
• CXC-Mediated Cellular Uptake of Miniproteins: Forsaking "Arginine Magic".

  2018cites this paper
• Biomaterials for polynucleotide delivery to anchorage-independent cells.

  2017cites this paper
• Precise quantification of cellular uptake of cell-penetrating peptides using fluorescence-activated cell sorting and fluorescence correlation spectroscopy.

  2016cites this paper
• Peptides for nucleic acid delivery.

  2016cites this paper
• The role of tryptophans on the cellular uptake and membrane interaction of arginine-rich cell penetrating peptides.

  2015cites this paper
• SCARA Involvement in the Uptake of Nanoparticles Formed by Cell-Penetrating Peptides.

  2015cites this paper
• Detecting Cytosolic Peptide Delivery with the GFP Complementation Assay in the Low Micromolar Range.

  2015cites this paper
• Delivery of therapeutic oligonucleotides with cell penetrating peptides☆

  2015cites this paper
• Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell

  2015influential citation
• Optimized luciferase assay for cell-penetrating peptide-mediated delivery of short oligonucleotides.

  2015cites this paper
• Identification and Characterization of Homing Peptides Using In Vivo Peptide Phage Display.

  2015cites this paper
• On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?

  2014cites this paper
• Bifunctional up-converting lanthanide nanoparticles for selective in vitro imaging and inhibition of cyclin D as anti-cancer agents.

  2014cites this paper
• Enantiomeric and Diastereoisomeric (Mixed) L/ D‐Octaarginine Derivatives – A Simple Way of Modulating the Properties of Cell‐Penetrating Peptides

  2013cites this paper
• Improved assays for determining the cytosolic access of peptides, proteins, and their mimetics.

  2013cites this paper
• Broad control of disulfide stability through microenvironmental effects and analysis in complex redox environments.

  2013cites this paper
• Screening of cell‐penetrating peptides using mRNA display

  2012cites this paper
• Oral biodrug delivery using cell-penetrating peptide.

  2012cites this paper
• Cell-penetrating Peptide-biodrug Strategy for Oral and Nasal Delivery: Review of Recent Findings

  2012cites this paper
• IMRE MÄGER Characterization of cell-penetrating peptides: assessment of cellular internalization kinetics, mechanisms and bioactivity

  2011cites this paper
• Measurements of the intracellular stability of CPPs.

  2011cites this paper
• Comparative analysis of the methods of drug and protein delivery for the treatment of cancer, genetic diseases and diagnostics

  2011cites this paper
• Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.

  2011cites this paper
• Retro-inversion of certain cell-penetrating peptides causes severe cellular toxicity.

  2011cites this paper
• Comparison of CPP uptake methods.

  2011cites this paper
• Efficient non-viral gene delivery mediated by nanostructured calcium carbonate in solution-based transfection and solid-phase transfection.

  2011cites this paper
• Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.

  2011cites this paper
• Building Cell Selectivity into CPP-Mediated Strategies

  2010cites this paper
• Structural requirements of penetratin absorption enhancement efficiency for insulin delivery.

  2010cites this paper
• MALDI-TOF mass spectrometry: a powerful tool to study the internalization of cell-penetrating peptides.

  2010cites this paper
• Assessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assay.

  2010cites this paper
• Structures, toxicity and internalization of cell-penetrating peptides

  2010cites this paper
• Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.

  2010cites this paper
• Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.

  2009cites this paper
• Effect of cell-penetrating peptides on the nasal absorption of insulin.

  2009cites this paper
• A peptide-based dendrimer that enhances the splice-redirecting activity of PNA conjugates in cells.

  2009cites this paper
• Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate.

  2009cites this paper
• An improved synthesis of releasable luciferin–CPP conjugates

  2009cites this paper
• Distinct uptake routes of cell-penetrating peptide conjugates.

  2008cites this paper
• Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers.

  2008cites this paper
• METHODS OF PROTEIN DELIVERY INTO MAMMALIAN CELLS FOR GENE THERAPY AND GENETIC STUDIES

  2008cites this paper
• Reversible sheet-turn conformational change of a cell-penetrating peptide in lipid bilayers studied by solid-state NMR.

  2008cites this paper
• DNA ANALOGS FOR THE PURPOSE OF GENE THERAPY

  2007cites this paper